| Financial Year |
March 31 2023 |
| Monetary Funds |
9,122,364,106.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
867,490,881.80 |
| Advances to Suppliers |
305,499,211.52 |
| Other Receivables |
290,566,953.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,765,723,929.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
350,726,090.04 |
| Total Current Assets |
24,489,410,547.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,550,417,626.54 |
| Investment Properties |
111,254,330.75 |
| Fixed Assetes |
38,063,451,073.55 |
| Under-construction Projects |
5,277,808,415.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
885,868,671.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,854,999.40 |
| Deferred Income Tax Assets |
355,329,318.91 |
| Other Non-Current Assets |
1,149,814,492.68 |
| Sub-Total of Non-Current Assets |
49,786,667,788.58 |
| Total Assets |
74,276,078,335.82 |
| Short-Term Loans |
1,659,745,524.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,572,250,920.46 |
| Accounts Payable |
10,153,204,305.41 |
| Accounts Received In Advance |
2,240,276.38 |
| Employee Compensation Payable |
34,489,465.78 |
| Taxes Payable |
187,619,945.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,403,927,202.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,759,838,471.38 |
| Other Current Liabilities |
517,493,681.74 |
| Sub-Total of Current Liabilities |
26,276,667,484.08 |
| Long-term Loans |
10,417,575,545.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
138,670,796.05 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,376,951.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,311,536,129.12 |
| Total Liabilities |
37,588,203,613.20 |
| Paid-In Capital(Or Share Stock) |
5,730,847,796.00 |
| Capital Surplus |
6,624,295,726.35 |
| Surplus Reserve |
3,072,977,050.63 |
| LESS:Treasury Stock |
127,674,000.00 |
| Undistributed Profits |
19,025,989,867.20 |
| Minority Stockholder's Interest |
2,456,531,809.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
34,231,342,913.14 |
| Owner's Equity（Stockholder's Equity） |
36,687,874,722.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
74,276,078,335.82 |
